Literature DB >> 26055956

Neurosyphilis presenting as a new onset lateralized movement disorder.

Nikolai Pfender1, Michael Linnebank1, Michael Sommerauer2, Alexander A Tarnutzer3.   

Abstract

We report a unique and illustrative case of a 52-year-old man with neurosyphilis presenting as subacute hemichorea, and discuss a vascular, metabolic or inflammatory origin. A broad range of neurological findings may be linked to neurosyphilis, potentially complicating its diagnosis. We propose that new onset lateralized movement disorders may constitute the initial clinical presentations of neurosyphilis, and provide evidence for striatal hypermetabolism pointing to direct inflammatory, syphilitic changes as the underlying pathophysiological mechanism. Neurosyphilis is no longer a common disorder, but the prevalence of syphilis is rising again in Western countries and its past reputation as the great imitator should not be forgotten.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hemichorea; Movement disorder; Neuroimaging; Neurological infectious disease; Neurosyphilis

Mesh:

Substances:

Year:  2015        PMID: 26055956     DOI: 10.1016/j.jocn.2015.03.038

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Clinical and Radiological Follow-Up of a Pfizer-BioNTech COVID-19 Vaccine-Induced Hemichorea-Hemiballismus; Insights Into Mechanisms of Basal Ganglia Dysfunction.

Authors:  Molly Cincotta; Ruth H Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-05-18

Review 2.  Usefulness of Positron Emission Tomography in Patients with Syphilis: A Systematic Review of Observational Studies.

Authors:  Jian-Hua Chen; Xin Zheng; Xiu-Qin Liu
Journal:  Chin Med J (Engl)       Date:  2017-05-05       Impact factor: 2.628

Review 3.  One Side of the Story; Clues to Etiology in Patients with Asymmetric Chorea.

Authors:  Molly Cincotta; Ruth H Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.